Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATF4 |
| Upstream (Parents) |
|---|
| (<<) ASNS → ATF4 |
| (<<) CDK4 → ATF4 |
| (<<) DAZAP2 → ATF4 |
| (<<) DDX21 → ATF4 |
| (<<) GNE → ATF4 |
| (<<) HSD11B1 → ATF4 |
| (<<) MTHFD2 → ATF4 |
| (<<) RBKS → ATF4 |
| (<<) ST3GAL1 → ATF4 |
| (<<) TRIB3 → ATF4 |
| Downstream (Children) |
|---|
| ATF4 → CHSY1 (>>) |
| ATF4 → DNAJA4 (>>) |
| ATF4 → EGFR (>>) |
| ATF4 → FZD3 (>>) |
| ATF4 → GALK1 (>>) |
| ATF4 → KPNA1 (>>) |
| ATF4 → SEH1L (>>) |
| ATF4 → SLPI (>>) |
| ATF4 → SOD2 (>>) |
| ATF4 → SOX1 (>>) |
| ATF4 → STC2 (>>) |
| ATF4 → STK16 (>>) |
